美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,263.55

-90.0978-6.66%

漲家數：1

跌家數：6

平家數：- -

市盈率：- -

高：1,362.19

開：1,356.11

低：1,242.41

收：1,353.23

資料載入中...

BUZZ-輝瑞公司季度利潤超預期，維持 2025 年預期；股價上漲

更正後的簡報-FDA 稱肝素鈉注射液，5000 [Usp'u]/1 毫升將因商業決定而停產 - 網站

美股異動丨輝瑞漲超3% Q1經調整每股盈利遠超預期擴大成本削減力度

輝瑞盤中異動早盤快速拉昇3.01%

輝瑞(PFE.N)漲近3%。

與諾和諾德達成合作協議 Hims & Hers Health漲超21%

美股異動 | 與諾和諾德(NVO.US)達成合作協議 Hims & Hers Health(HIMS.US)漲超21%

異動 | HIMS飆升逾26%，LFMD大漲逾21%，兩家公司均與諾和諾德合作出售減肥藥Wegovy

老虎资讯综合

碩迪生物盤中異動股價大漲5.46%報24.91美元

諾和諾德盤中異動早盤快速拉昇4.01%報65.13美元

Viking Therapeutics, Inc.盤中異動股價大漲5.36%報27.33美元

BUZZ-輝瑞公司季度利潤增長，維持 2025 年業績預期

輝瑞依靠削減成本抵消收入下降的影響

輝瑞季度銷售額不及預期，COVID 治療收入下降

諾和諾德4月28日成交額為3.93億美元

安進4月28日成交額為5.89億美元

歐股“十一羅漢”收盤播報｜諾和諾德收漲將近2.7%，阿斯麥則跌超0.7%

Viking Therapeutics, Inc.盤中異動急速上漲5.04%

諾和諾德肥胖症藥物 Wegovy 首次在泰國上市

諾納生物合作伙伴輝瑞在2025 AACR年會上公佈基於TOP1i靶向人間皮素ADC療法的臨牀前數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1263.1277,"timestamp":1746127849814,"preClose":1353.2255,"halted":0,"volume":63056679,"delay":0,"changeRate":-0.06658,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-90.097778,"latestTime":"05-01 15:30:50 EDT","open":1356.1058,"high":1362.19,"low":1242.4124,"amount":10841522936.05785,"amplitude":0.088513,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.487449,"peRate":36.838608,"turnoverRate":0.005969,"increases":1,"decrements":6,"flats":0,"marketCap":1351514442912,"floatMarketCap":1266432645216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1362.19,"amplitude":0.088513,"preClose":1353.2255,"low":1242.4124,"pbRate":"10.487449","latestPrice":1263.5548,"volume":63060137,"delay":0,"open":1356.1058,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1291.0822,"twentyDayClose":1296.1409,"sixtyDayClose":1354.5123,"secType":"PLATE","market":"US","turnoverRate":0.005969,"peRate":36.838608,"marketCap":1351417470368,"floatMarketCap":1266335874400,"timestamp":1746127852392,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":1,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531766955","title":"BUZZ-輝瑞公司季度利潤超預期，維持 2025 年預期；股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2531766955","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531766955?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 00:41","pubTimestamp":1745944911,"startTime":"0","endTime":"0","summary":"** 由于 Paxlovid COVID-19 疗法销售额下降，PFE 第一季度营收不及预期，但该公司仍 坚持610 亿至 640 亿美元的财年营收预期。** 包括本交易日的走势在内，PFE 在今年已累计下跌约10(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R723X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0122379950.USD","LU1066053197.SGD","IE00BBT3K403.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","LU0868494617.USD","BK4568","LU1057294990.SGD","SG9999013999.USD","BK4533","PFE","BK4581","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","LU0321505868.SGD","LU1894683348.USD","IE0002270589.USD","BK4007","LU1066051498.USD","LU1894683264.USD","BK4599","SG9999003800.SGD","LU0225771236.USD","LU1883839398.USD","LU0321505439.SGD","IE000M9KFDE8.USD","BK4534","LU0225284248.USD","BK4588","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4592","LU0306806265.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0306807586.USD","IE00BLSP4239.USD","BK4550","SG9999001176.USD","LU0058720904.USD","LU0985481810.HKD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2531752002","title":"更正後的簡報-FDA 稱肝素鈉注射液，5000 [Usp'u]/1 毫升將因商業決定而停產 - 網站","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752002","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531752002?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 23:24","pubTimestamp":1745940292,"startTime":"0","endTime":"0","summary":"更正后的简报-FDA 称肝素钠注射液，5000 [Usp'u]/1 毫升将因商业决定而停产 - 网站来源更正为美国食品及药物管理局，而非辉瑞公司路透4月29日 - 美国食品和药物管理局：FDA：肝素钠，注射剂，5000[USP'U]/1 毫升，因商业决定将停产 - 网站(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R71YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","BK4550","LU0985481810.HKD","LU1883839398.USD","IE000M9KFDE8.USD","LU0456855351.SGD","SG9999011175.SGD","LU1066053197.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU0306806265.USD","SG9999002232.USD","LU1023059063.AUD","LU1057294990.SGD","BK4534","BK4592","LU0225771236.USD","SGXZ57979304.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4599","BK4581","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","LU1894683348.USD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","SG9999013999.USD","SG9999002224.SGD","BK4568","IE0002270589.USD","LU0868494617.USD","LU0289739699.SGD","LU1894683264.USD"],"gpt_icon":0},{"id":"2531757594","title":"美股異動丨輝瑞漲超3% Q1經調整每股盈利遠超預期 擴大成本削減力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757594","media":"格隆汇APP","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531757594?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 23:11","pubTimestamp":1745939460,"startTime":"0","endTime":"0","summary":"格隆汇4月29日｜辉瑞(PFE.US)涨超3%，报23.755美元。消息面上，辉瑞周二公布，在加大成本削减力度下，首季净利润同比跌约5%至29.7亿美元，经调整每股盈利92美仙，远高于市场预期的66美仙；营收同比跌8%至137.2亿美元，反映其抗病毒药物Paxlovid的收入减少。公司预计，通过两项成本削减措施，到2027年底将节省约77亿美元。公司维持对2025年全年财报的预期，预计销售额为610亿至640亿美元，惟补充该指引目前不包括与未来关税和贸易政策变化相关的任何潜在影响。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-29/doc-ineuwcvn0721829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","LU0321505868.SGD","LU0225284248.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0225771236.USD","BK4534","SG9999003800.SGD","IE0002270589.USD","SG9999013999.USD","LU0122379950.USD","BK4581","BK4585","IE00BLSP4239.USD","LU0306807586.USD","LU1894683264.USD","LU0234572021.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","BK4599","BK4588","BK4007","IE00BBT3K403.USD","BK4568","SGXZ57979304.SGD","PFE","SG9999001176.USD","IE00B19Z3581.USD","BK4592","LU0321505439.SGD","LU1066051498.USD","LU0306806265.USD","SG9999002224.SGD","LU0868494617.USD","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","LU0170899867.USD","LU1057294990.SGD","LU0456855351.SGD","BK4533"],"gpt_icon":0},{"id":"2531545567","title":"輝瑞盤中異動 早盤快速拉昇3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531545567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531545567?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 22:50","pubTimestamp":1745938226,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时50分，辉瑞股票出现异动，股价急速拉升3.01%。截至发稿，该股报23.74美元/股，成交量3271.13万股，换手率0.58%，振幅5.53%。辉瑞股票所在的制药行业中，整体涨幅为1.01%。辉瑞公司简介：辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。与其他受贸易政策变化影响的公司不同，辉瑞并未调整其业绩预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429225026aa2c7e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429225026aa2c7e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2531751539","title":"輝瑞(PFE.N)漲近3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531751539","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531751539?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 22:48","pubTimestamp":1745938133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4568","BK4588","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","IE00BBT3K403.USD","BK4599","LU1066051498.USD","LU1066053197.SGD","PFE","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","BK4007","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","LU0456855351.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","BK4533","SG9999003800.SGD","LU1894683348.USD","LU0122379950.USD","LU0058720904.USD","LU1894683264.USD","SG9999011175.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0289739699.SGD","LU0985481810.HKD","BK4581","LU0321505868.SGD","BK4592","BK4585","LU1023059063.AUD","SGXZ57979304.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"2531756744","title":"與諾和諾德達成合作協議 Hims & Hers Health漲超21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531756744?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 22:04","pubTimestamp":1745935494,"startTime":"0","endTime":"0","summary":"周二，美国远程医疗公司Hims&Hers Health股价拉涨，截至发稿，该股涨超21%，报34.81美元。根据协议内容，诺和诺德旗下的直销平台NovoCare Pharmacy将可通过Hims&Hers网站进行访问，前提是用户需持有Hims&Hers会员身份，且所有剂量版本的Wegovy都将上线。双方表示，此次打包产品的发布只是长期合作的第一步，预计将于本周内在Hims&Hers平台上线。这项合作对总部位于旧金山的Hims&Hers而言是一个关键转折点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429221534a46c4b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429221534a46c4b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","BK4007","NVO","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","BK4532","BK4599"],"gpt_icon":1},{"id":"2531753197","title":"美股異動 | 與諾和諾德(NVO.US)達成合作協議 Hims & Hers Health(HIMS.US)漲超21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531753197","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531753197?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:55","pubTimestamp":1745934918,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，美国远程医疗公司Hims & Hers Health股价拉涨，截至发稿，该股涨超21%，报34.81美元。此前该公司宣布与丹麦制药巨头诺和诺德达成合作协议，将通过其平台销售诺和诺德广受欢迎的减重药物Wegovy。双方表示，此次打包产品的发布只是长期合作的第一步，预计将于本周内在Hims & Hers平台上线。这项合作对总部位于旧金山的Hims & Hers而言是一个关键转折点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","LU1093756325.SGD","HIMS","BK4532","BK4588","LU1093756168.USD","BK4196","BK4585"],"gpt_icon":1},{"id":"1173179156","title":"異動 | HIMS飆升逾26%，LFMD大漲逾21%，兩家公司均與諾和諾德合作出售減肥藥Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1173179156","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173179156?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:48","pubTimestamp":1745934517,"startTime":"0","endTime":"0","summary":"4月26日，截止发稿，HIMS盘中飙升逾26%，LFMD盘中大涨逾21%。消息方面：两家公司均与$诺和诺德(NVO)$合作出售减肥药Wegovy。","market":"us","thumbnail":"https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVO","HIMS","IE00BZ1G4Q59.USD","LFMD","LU0154236417.USD","BK4585","BK4183","BK4588","BK4599","BK4007","BK4167","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD","BK4196"],"gpt_icon":0},{"id":"2531758632","title":"碩迪生物盤中異動 股價大漲5.46%報24.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531758632?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:44","pubTimestamp":1745934289,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时44分，硕迪生物股票出现异动，股价大幅上涨5.46%。截至发稿，该股报24.91美元/股，成交量4.824万股，换手率0.08%，振幅2.43%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2531589537","title":"諾和諾德盤中異動 早盤快速拉昇4.01%報65.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531589537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531589537?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:31","pubTimestamp":1745933495,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，诺和诺德股票出现异动，股价急速上涨4.01%。截至发稿，该股报65.13美元/股，成交量127.066万股，换手率0.03%，振幅0.30%。最近的财报数据显示，该股实现营业收入421.15亿美元，净利润146.46亿美元，每股收益3.29美元，毛利353.13亿美元，市盈率20.66倍。诺和诺德股票所在的制药行业中，整体跌幅为0.18%。其中，阿斯利康重返销冠宝座，诺华大涨超20%。近日，各大跨国药企2024年财报陆续出炉，7家跨国药企在中国的营收也浮出水面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213138a46c3f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213138a46c3f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4599","IE00BKVL7J92.USD","BK4007","BK4588","BK4532","LU0154236417.USD","NVO","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"gpt_icon":1},{"id":"2531737572","title":"Viking Therapeutics, Inc.盤中異動 股價大漲5.36%報27.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531737572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531737572?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 21:31","pubTimestamp":1745933467,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，Viking Therapeutics, Inc.股票出现异动，股价快速拉升5.36%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。该信息摘要如下：Viking Therapeutics获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4588","BK4585","VKTX","BK4599"],"gpt_icon":0},{"id":"2531641786","title":"BUZZ-輝瑞公司季度利潤增長，維持 2025 年業績預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531641786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531641786?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 19:02","pubTimestamp":1745924560,"startTime":"0","endTime":"0","summary":"** 虽然第一季度营收不及预期，但仍坚持610-640亿美元的财年营收预期 ** 同时，维持 2.80 美元至 3.00 美元的财年每股收益预期。** 截至上次收盘，PFE 年累计下跌约 13 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R7114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0321505868.SGD","LU1023059063.AUD","PFE","BK4585","BK4534","LU1057294990.SGD","SG9999002224.SGD","BK4007","LU0058720904.USD","BK4581","LU0868494617.USD","LU0306807586.USD","SG9999011175.SGD","BK4568","LU1066051498.USD","LU0456855351.SGD","BK4533","SG9999003800.SGD","LU0321505439.SGD","BK4599","LU0122379950.USD","LU1894683348.USD","LU0225771236.USD","BK4550","LU0306806265.USD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0289739699.SGD","LU1894683264.USD","LU0170899867.USD","LU1066053197.SGD","LU0985481810.HKD","SG9999001176.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU1883839398.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0234572021.USD","BK4588","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2531785467","title":"輝瑞依靠削減成本抵消收入下降的影響","url":"https://stock-news.laohu8.com/highlight/detail?id=2531785467","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531785467?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924425,"startTime":"0","endTime":"0","summary":"更新版 6-辉瑞依靠削减成本抵消收入下降的影响辉瑞公布喜忧参半的第一季度业绩，维持全年预期 COVID 疫苗销售好于预期，而抗病毒治疗销售下降预计到 2027 年底可节省 77 亿美元成本 第 8-9 段增加了首席执行官访谈中关于关税的评论Bhanvi Satija/Michael Erman. 路透4月29日 - 辉瑞PFE.N周二表示，公司将通过削减生产和研究业务的成本再节约17亿美元，尽管由于其COVID-19治疗药物Paxlovid的销售下降导致第一季度收入减少，但辉瑞仍强调了其运营效率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R7108:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2531378394","title":"輝瑞季度銷售額不及預期，COVID 治療收入下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2531378394","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531378394?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 18:49","pubTimestamp":1745923795,"startTime":"0","endTime":"0","summary":"辉瑞季度销售额不及预期，COVID 治疗收入下降路透4月29日 - 美国制药商辉瑞PFE.N周二公布的第一季度收入低于华尔街预期，受其COVID抗病毒治疗药物Paxlovid销售下滑的影响。 LSEG的数据显示，该公司第一季度总营收为137.0亿美元，而分析师预期为139.1亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R70Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","LU0225771236.USD","PFE","SG9999001176.USD","LU0456855351.SGD","SG9999001176.SGD","BK4550","SGXZ57979304.SGD","LU1894683348.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2531212892","title":"諾和諾德4月28日成交額為3.93億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531212892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531212892?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:13","pubTimestamp":1745892796,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，诺和诺德成交额为3.93亿美元，成交额较昨日减少18.75%，当日成交量为628.03万股。诺和诺德于2025年4月28日涨0.87%，报62.62美元，该股过去5个交易日涨7.35%，年初至今跌26.22%，过去60日跌25.63%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429101317a46b510f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429101317a46b510f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4588"],"gpt_icon":1},{"id":"2531213559","title":"安進4月28日成交額為5.89億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531213559?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:15","pubTimestamp":1745889357,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，安进成交额为5.89亿美元，成交额较昨日增加5.29%，当日成交量为208.25万股。安进于2025年4月28日涨0.8%，报283.09美元，该股过去5个交易日涨3.44%，年初至今涨9.49%，过去60日涨0.48%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1061106388.HKD","BK4139","LU0122379950.USD","BK4581","BK4588","LU0320765992.SGD","LU0058720904.USD","BK4599","IE0002141913.USD","LU1057294990.SGD","LU0868494617.USD","LU2112291526.USD","LU2468319806.SGD","BK4585","SG9999001440.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1983299246.USD","LU0109394709.USD","IE00B4R5TH58.HKD","AMGN","LU2242646821.SGD","BK4533","LU1571399168.USD","LU0889565916.HKD","BK4566","LU0289739699.SGD","BK4534"],"gpt_icon":0},{"id":"2531253847","title":"歐股“十一羅漢”收盤播報｜諾和諾德收漲將近2.7%，阿斯麥則跌超0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531253847","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531253847?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 01:15","pubTimestamp":1745860542,"startTime":"0","endTime":"0","summary":"周一，阿斯麦控股荷兰阿姆斯特丹股价收跌0.75%，报584.50欧元。诺和诺德哥本哈根股价收涨2.68%，报414.30。德国思爱普Sap、葛兰素史克、欧莱雅、罗氏制药、阿斯利康、雀巢涨1.68%-1.18%，诺华、赛诺菲、LVMH集团至多涨0.93%。在欧洲奢侈品概念股中，博柏利、雨果博斯、开云集团涨2.94%-2.29%。在意大利银行股中，Banca Sistema SpA.涨6.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901181294e62c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901181294e62c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0097036916.USD","03165","LU1093756168.USD","IE0004445239.USD","IE00BKVL7J92.USD","ASML","BK4147","LU1734074674.USD","LU0823434583.USD","BK4532","LU1093756325.SGD","NVO","BK4585","IE00BD6J9T35.USD","BK4007","BK4588","IE00BZ1G4Q59.USD","LU0823434740.USD","LU0154236417.USD","LU2063271972.USD","LU0345774391.USD","LU0345774631.USD","BK4543","BK4599"],"gpt_icon":0},{"id":"2530228954","title":"Viking Therapeutics, Inc.盤中異動 急速上漲5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530228954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530228954?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:43","pubTimestamp":1745847819,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Viking Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1597.19%、344.10%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","VKTX","BK4599","BK4007","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2530242608","title":"諾和諾德肥胖症藥物 Wegovy 首次在泰國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2530242608","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530242608?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 17:01","pubTimestamp":1745830918,"startTime":"0","endTime":"0","summary":"路透曼谷4月28日 - 丹麦诺和诺德NOVOb.CO公司当地子公司的一位高管周一表示，该公司已在泰国推出了大受欢迎的减肥药Wegovy，这标志着该注射药物首次进入东南亚市场。Bruland拒绝透露Wegovy在泰国的定价细节，也拒绝透露诺和诺德进军其他东南亚市场的计划。Bruland说，Wegovy目前在泰国各地的私立医院有处方药出售，不久将在公立医院上市。诺和诺德的糖尿病药物 Ozempic 与 Wegovy 的活性成分相同，已经在泰国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4S3R60O2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004445239.USD","LU0109391861.USD","LU1127390331.HKD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU2461242641.AUD","LU1023059063.AUD","LU1623119135.USD","LU2471134879.HKD","LU0640476718.USD","LU2237443549.SGD","BK4581","LU2491049909.HKD","SG9999015952.SGD","SGXZ99366536.SGD","LU1983299246.USD","SG9999015986.USD","LU1868836591.USD","BK4588","BK4599","LU0943347566.SGD","LU2471134952.CNY","LU0203201768.USD","LU0203202063.USD","LU2264538146.SGD","BK4534","LU1712237335.SGD","LU1988902786.USD","LU2063271972.USD","LU1868837136.USD","LU0256863811.USD","LU2112291526.USD","LU1551013342.USD","LU0672654240.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU0456855351.SGD","SG9999015978.USD","LU0823416689.USD","LU0198837287.USD","IE00BK4W5M84.HKD","BK4007","LU0097036916.USD","LU0058720904.USD","LU2491050071.SGD","LU1804176565.USD","LU1069344957.HKD","LU2106854487.HKD"],"gpt_icon":1},{"id":"2530497866","title":"諾納生物合作伙伴輝瑞在2025 AACR年會上公佈基於TOP1i靶向人間皮素ADC療法的臨牀前數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2530497866","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530497866?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:31","pubTimestamp":1745800285,"startTime":"0","endTime":"0","summary":"诺纳生物，一家致力于前沿技术创新，并为合作伙伴提供涵盖靶点验证和新一代生物大分子药物从发现至临床前研发等Idea to IND完整服务的国际化创新生物技术公司，今日宣布其合作伙伴辉瑞在2025年美国癌症研究协会年会上公布了同类首创基于拓扑异构酶1抑制剂的靶向人间皮素抗体偶联药物PF-08052666的临床前数据。2023年12月14日，辉瑞获得了其全球临床开发和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","BK4231","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4080","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","ADC","LU0456855351.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123,"code":"91000000","status":"200"}]}}